Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Wenzel

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|August 13, 2003
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilitiesHilmar Wisplinghoff, Harald Seifert, Sandra M Tallent, et al.
The Journal of Infection|October 29, 2005
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosaAlexandre R Marra, Katharine Bar, Gonzalo M L Bearman, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2008
Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic reviewMiranda M L van Rijen, Marc Bonten, Richard P Wenzel, et al.
Journal of Clinical Microbiology|April 7, 2006
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infectionAlexandre R Marra, Michael B Edmond, Betty A Forbes, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapyRichard P Wenzel, Daniel F Sahm, Clyde Thornsberry, et al.
Annals of Clinical Microbiology and Antimicrobials|July 31, 2004
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)Mark E Jones, Deborah C Draghi, Clyde Thornsberry, et al.
International Journal of Antimicrobial Agents|November 5, 2013
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilitiesHilmar Wisplinghoff, Jenny Ebbers, Lea Geurtz, et al.
The New England Journal of Medicine|April 26, 2023
Audio Interview: Preparing for the Next PandemicEric J Rubin, Lindsey R Baden, Quarraisha Abdool Karim, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Preoperative risk factors for nasal carriage of Staphylococcus aureusLoreen A Herwaldt, Joseph J Cullen, Pamela French, et al.
The Journal of Infection|January 3, 2012
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United StatesHilmar Wisplinghoff, Tobias Paulus, Marianne Lugenheim, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|August 13, 2003
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilitiesHilmar Wisplinghoff, Harald Seifert, Sandra M Tallent, et al.
The Journal of Infection|October 29, 2005
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosaAlexandre R Marra, Katharine Bar, Gonzalo M L Bearman, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2008
Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic reviewMiranda M L van Rijen, Marc Bonten, Richard P Wenzel, et al.
Journal of Clinical Microbiology|April 7, 2006
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infectionAlexandre R Marra, Michael B Edmond, Betty A Forbes, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapyRichard P Wenzel, Daniel F Sahm, Clyde Thornsberry, et al.
Annals of Clinical Microbiology and Antimicrobials|July 31, 2004
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)Mark E Jones, Deborah C Draghi, Clyde Thornsberry, et al.
International Journal of Antimicrobial Agents|November 5, 2013
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilitiesHilmar Wisplinghoff, Jenny Ebbers, Lea Geurtz, et al.
The New England Journal of Medicine|April 26, 2023
Audio Interview: Preparing for the Next PandemicEric J Rubin, Lindsey R Baden, Quarraisha Abdool Karim, et al.
Infection Control and Hospital Epidemiology|July 10, 2004
Preoperative risk factors for nasal carriage of Staphylococcus aureusLoreen A Herwaldt, Joseph J Cullen, Pamela French, et al.
The Journal of Infection|January 3, 2012
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United StatesHilmar Wisplinghoff, Tobias Paulus, Marianne Lugenheim, et al.
Pageof 8